On 5 May the SA Health Products Regulatory Authority (SAPHRA) approved Aspen Pharmacare’s local manufacturing of the first human insulin batches. – Moneyweb (7 May 2026)
The sterile insulin, manufactured in Gqeberha, Eastern Cape, may now be sold in SA and other African markets.
“After Aspen’s SENS update on 5 May the company’s share price reached a 52-week high, lifting its market capitalisation above R66bn.”
Diabetes is now “the single biggest killer in the country” among non-communicable diseases.